Elite Health Systems Inc. (EHSI) stock

EHSIOTCServices-Specialty Outpatient Facilities, NECFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 5/30

$0.76+0.00 (0.00%)

Close on Oct 19, 2026Market cap $21.68MP/E –Yield –

Elite Health Systems price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Elite Health Systems's price to sales ratio was 5.8× on Oct 19, 2026, against 0.8× a year earlier. Over the last 5 years it ranged from 0.4× to 35.1×, with a median of 0.7×.

Price to Sales Ratio at the end of each year

Period	Period end	Value	Change (pts)
2026	Oct 19, 2026	5.8×	+4.3
2022	Apr 29, 2022	1.5×	+0.7
2021	Dec 31, 2021	0.8×	+0.0
2020	Dec 31, 2020	0.8×	+0.2
2019	Dec 31, 2019	0.5×	+0.1
2018	Dec 31, 2018	0.5×	–

Where these numbers come from

Parsed from the XBRL in Elite Health Systems's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is EHSI.

Compare: EHSI vs PFHO · EHSI vs MRAI · EHSI vs BICX · EHSI vs MCTA · EHSI vs EUDA

Operating margin-155.6% · median -32.5%

Net margin-261.7% · median -40.4%

Company	Revenue	Growth
MRAI	$17.02M	-17.8%
PFHO	$6.37M	-5.8%
EHSI	$3.73M	–
BICX	–	–
MCTA	–	–
EUDA	–	–

Company

Exchange: OTC
Industry: Services-Specialty Outpatient Facilities, NEC
Fiscal year ends: December 31
Employees: 10
Auditor: Mercurius & Associates LLP
SEC CIK: 1089815

Advertisement
300 × 250

See a number that looks wrong?

Elite Health Systems price to sales ratio

Price to Sales Ratio at the end of each year

More Elite Health Systems figures